KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cameco (CCJ) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Cameco (CCJ) over the last 16 years, with Q4 2025 value amounting to $1.1 billion.

  • Cameco's Cash & Equivalents rose 15936.61% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year increase of 15936.61%. This contributed to the annual value of $1.1 billion for FY2025, which is 15419.93% up from last year.
  • Cameco's Cash & Equivalents amounted to $1.1 billion in Q4 2025, which was up 15936.61% from $778.7 million recorded in Q3 2025.
  • Cameco's Cash & Equivalents' 5-year high stood at $2.0 billion during Q3 2023, with a 5-year trough of $197.1 million in Q3 2024.
  • In the last 5 years, Cameco's Cash & Equivalents had a median value of $821.8 million in 2021 and averaged $838.8 million.
  • Per our database at Business Quant, Cameco's Cash & Equivalents plummeted by 9009.31% in 2024 and then surged by 29497.36% in 2025.
  • Over the past 5 years, Cameco's Cash & Equivalents (Quarter) stood at $989.6 million in 2021, then decreased by 14.86% to $842.5 million in 2022, then plummeted by 50.59% to $416.3 million in 2023, then grew by 3.24% to $429.8 million in 2024, then soared by 159.37% to $1.1 billion in 2025.
  • Its Cash & Equivalents was $1.1 billion in Q4 2025, compared to $778.7 million in Q3 2025 and $716.3 million in Q2 2025.